Codes / ICD10CM / T48.3X6D

T48.3X6D Underdosing of antitussives, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Underdosing of antitussives, subsequent encounter

Summary

This condition describes insufficient dosing of antitussive medications during a subsequent encounter, where the underdosing was a focus of previous care. Antitussives are used to suppress coughing, and underdosing may result from dosing errors, patient non-adherence, or pharmacokinetic factors reducing drug efficacy. Clinical outcomes can include persistent coughing or inadequate symptom control.

Causes

Underdosing may occur due to incorrect administration, missed doses, or subtherapeutic drug levels. Factors like poor medication adherence, dosing miscalculations, or interactions affecting absorption can contribute. In some cases, it may stem from intentional dose reduction or therapeutic errors.

Risk Factors

  • Use of antitussives with narrow therapeutic windows.
  • Patient non-adherence to prescribed regimens.
  • Concurrent medications altering drug metabolism.
  • Renal or hepatic impairment affecting drug clearance.
  • Lack of clear dosing instructions or patient education.

Symptoms

  • Persistent or worsening cough.
  • Inadequate relief of cough-related symptoms.
  • Possible recurrence of underlying respiratory symptoms.
  • Variable presentation depending on the specific antitussive and dose.

Diagnosis

Clinical evaluation focuses on medication history, dosing patterns, and symptom response. Review of prescription records, patient adherence, and potential drug interactions helps confirm the underdosing. Laboratory tests may assess drug levels if needed.

Treatment Options

Management involves adjusting the antitussive dose, improving adherence, or addressing underlying factors. This may include re-education on proper administration, switching to a more suitable formulation, or treating the underlying cause of the cough.

Prognosis and Follow-Up

Prognosis depends on the severity of underdosing and response to intervention. Follow-up ensures adequate symptom control and addresses any ongoing adherence issues. Regular monitoring of cough and medication use is recommended.

Complications

Persistent coughing may lead to sleep disturbance, fatigue, or exacerbation of underlying respiratory conditions. In severe cases, inadequate symptom control could worsen respiratory function.

Lifestyle & Prevention

  • Ensure clear dosing instructions and patient education.
  • Use medication organizers or reminders to improve adherence.
  • Avoid concurrent use of drugs that may interact with antitussives.
  • Store medications securely to prevent accidental misuse or dosing errors.

When to Seek Professional Help

Seek care if cough persists despite treatment, symptoms worsen, or new respiratory issues develop. Prompt evaluation is needed for severe or uncontrolled coughing.

Tips for Medical Coders

Document the subsequent encounter context, including prior underdosing and current treatment adjustments. Ensure clinical notes specify the underdosing as the reason for the encounter to support accurate coding.

Book a walkthrough

T48.3X6D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.